Dr Lal PathLabs completes acquisition of SN Genelab
after close1 source ↓written by the desknot a recommendation
- SN Genelab
- 1 Oct 2026
Dr Lal PathLabs has successfully completed its acquisition of a stake in SN Genelab on 1 Oct 2026. This move aligns with its strategy to enhance diagnostic capabilities through selective M&A. The company did not disclose the stake size or transaction value, leaving investors to reference prior announcements for details. 📈
The acquisition is expected to bolster Dr Lal PathLabs' market position in the diagnostics sector, potentially impacting investor sentiment in the near term.
Not investment advice. For informational purposes only.